A follow-up MSCT of the abdomen showed a 12-mm thickening of the cholecyst wall - a regression, compared to the initial MSCT result - and increased tumour marker levels (CEA 1.6 μg/l, CA 19-9 2,525 U/ml). Here, CEACAM5 is linked to neoplasm.